Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide.

Castro, T B M

Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide. [electronic resource] - Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2016 - e5128 p. digital

Publication Type: Journal Article; Multicenter Study; Observational Study

1414-431X

10.1590/1414-431X20165128 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bortezomib--adverse effects
Diarrhea--chemically induced
Female
Humans
Immunosuppressive Agents--adverse effects
Male
Middle Aged
Multiple Myeloma--drug therapy
Neutropenia--chemically induced
Peripheral Nervous System Diseases--chemically induced
Pharmacovigilance
Prospective Studies
Risk Factors
Thalidomide--adverse effects
Treatment Outcome